Determinants of uraemic toxin removal

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 3, 2002, Pages 30-34

  Clark, William R ^a,b,d   Gao, Dayong ^c  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

Convection; Diffusion; Haemodialysis; Peritoneal dialysis; Solute

Indexed keywords

UREMIC TOXIN;

ARTICLE; CONTROLLED STUDY; FREQUENCY ANALYSIS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; PRIORITY JOURNAL; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME; UREMIA; URINARY EXCRETION;

EID: 0036235168     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_3.30     Document Type: Article

References (36)

1. Low-molecular weight proteins in end-stage renal disease: Potential toxicity and dialytic removal mechanisms
2. Metabolism of complement factor D in renal failure
3. Weight-reduction effects of the plasma protein encoded by the obese gene
4. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
5. Serum immunoreactive leptin concentrations in normal-weight and obese humans
6. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients
7. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure
8. Leptin, body composition and indices of malnutrition in patients on dialysis
9. Association of the serum leptin concentration with weight loss in chronic hemodialysis patients
10. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis and hemodialysis: A comparative analysis
11. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass
12. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
13. Urea kinetics and when to commence dialysis
14. Timely initiation of dialysis: A urea kinetic approach
15. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
16. The influence of dialysis treatment modality on the decline of remaining renal function
17. Renal vs continuous vs intermittent therapies for removal of uremic toxins
18. The equivalent renal urea clearance: A new parameter to assess dialysis dose
19. The current place of urea kinetic modeling with respect to different dialysis modalities
20. Back-diffusion of urea in the mammalian kidney
21. The excretion of urea in normal man and in subjects with glomerulonephritis
22. Overestimation of hemodialysis dose (ΔKt/V) depends on dialysis efficiency (K/V) by regional blood flow but not by conventional two pool urea kinetic analysis
23. Whither goest Kt/V?
24. Kt/V is the best dialysis dose parameter
25. Principles and practice of hemofiltration and hemodiafiltration
26. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for post-dilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate
27. Change from conventional haemodiafiltration to on-line haemodiafiltration
28. On-line haemodiafiltration vs low-flux haemodialysis: A prospective randomized study
29. On-line haemodiafiltration: Remarkable removal of β2-microglobulin
30. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study
31. Effects of reduced inner diameter of hollow fibers in hemodialyzers
32. Rebound kinetics of β2-microglobulin after hemodialysis
33. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model
34. Failure of daily hemofiltration programme using a highly permeable membrane to return β2-microglobulin concentrations to normal in haemodialysis patients
35. β2-microglobulin kinetics in nocturnal haemodialysis
36. Quantification of middle molecule removal in dialysis